Multiple studies conducted in the U.S. and U.K. between 2011 – 2015 and beyond proved that regenerative therapy has shown incredible promise and results in helping reduce destructive inflammation and immune response to stroke injury as well as risk for serious infections. Those benefits continue for months after the injection. Researchers have found post-stroke inflammation is a response that prevents natural healing in the body and that when patients receive cell therapy, they had lower blood levels of inflammatory signals – called cytokines compared to stroke patients who did not receive regenerative therapy.
According to the American Heart Association, stroke is the leading cause of long-term disability and the leading preventable cause of disability in the U.S., however regenerative therapy can significantly improve and reduce disability in patients, long-term. Other benefits of cellular therapy include: